Korean drug makers in sales quagmire

Published: 2013-09-02 07:00:00

Updated: 2013-09-02 07:00:00

Korean drug companies are trying to survive the government’s price cuts by slashing production costs and collaborating with foreign companies to sell products. But those measures have not been enough to stop a fall in sales, while the financial structure of local firm will further worsen due to l...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK